This content is machine translated Non-Hodgkin's Lymphoma “The new drugs will fundamentally change the therapeutic landscape” In an interview with InFo ONCOLOGY & HEMATOLOGY, Prof. Christoph Driessen, MD, Head Physician of the Department of Oncology/Hematology at the Cantonal Hospital St. Gallen, provides information on the pathogenesis,…
View Post 6 min This content is machine translated Suspicion of lung carcinoma Silent preclinical lung findings complicate diagnosis Lung carcinoma usually presents to the general practitioner as advanced disease with mostly nonspecific symptoms: As a silent preclinical lung finding, it must be specifically sought. Knowledge of the clinical…
